Alex is the Director and founder of Symmetron.

He has expertise in many areas of health economic evaluation. He has developed studies and provided strategic advice to help many companies overcoming the challenges in generating, synthesising and evaluating health economic evidence in order to achieve market access. He has designed economic evaluations and other market access tools in Europe, USA, Canada, Australia and several countries of East Asia.

His research interests include decision-analytic modelling, use of statistical methods in economic evaluations and indirect treatment comparisons. He has completed research in a range of therapeutic areas including oncology, diabetes, rheumatoid arthritis, heart disease, mental health and behavioural conditions, neurological conditions, paediatric diseases, diagnostics, and various applications of medical devices. An economist by training, Alex has an MSc from the University of Birmingham.